US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist

1.720
+0.100+6.17%

Close Nov 22 16:00 ET

1.730
+0.010+0.58%

Post 18:16 ET

45.62MMarket Cap-1607P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-60.62%55.18K

22.61%55.18K

-15.08%140.11K

Operating revenue

--0

-58.40%55.18K

--0

47.00%55.18K

-0.96%132.64K

--0

Cost of revenue

Gross profit

Operating expense

-8.72%4.46M

5.84%8.18M

-17.17%4.38M

24.51%22.31M

-3.38%4.41M

2.82%4.89M

46.66%7.73M

58.54%5.28M

28.06%17.92M

40.26%4.56M

Selling and administrative expenses

-27.02%1.84M

0.05%3.75M

-24.98%1.87M

13.08%10.79M

-11.11%2.03M

-9.64%2.52M

39.19%3.74M

40.33%2.49M

39.74%9.54M

28.54%2.29M

-General and administrative expense

-27.02%1.84M

0.05%3.75M

-24.98%1.87M

13.08%10.79M

-11.11%2.03M

-9.64%2.52M

39.19%3.74M

40.33%2.49M

39.74%9.54M

28.54%2.29M

Research and development costs

10.74%2.62M

11.28%4.44M

-10.19%2.51M

37.52%11.52M

4.40%2.37M

20.50%2.37M

54.44%3.99M

79.33%2.79M

16.93%8.38M

54.42%2.27M

Operating profit

8.72%-4.46M

-5.84%-8.18M

16.29%-4.38M

-25.18%-22.25M

3.38%-4.41M

-2.82%-4.89M

-49.35%-7.73M

-59.03%-5.23M

-28.58%-17.78M

-42.15%-4.56M

Net non-operating interest income expense

-0.56%105.41K

-34.94%84.53K

-24.16%115.3K

31.67%494.23K

-35.11%106.27K

-30.87%106K

116.91%129.93K

9,308.66%152.04K

2,904.06%375.36K

61,239.70%163.78K

Non-operating interest income

----

31.67%494.23K

----

--375.36K

----

Total other finance cost

0.56%-105.41K

34.94%-84.53K

24.16%-115.3K

----

30.87%-106K

---129.93K

-9,308.66%-152.04K

----

Other net income (expense)

-247.37%-121.14K

27.61%-43.58K

725.73%268.08K

-346.89%-429.35K

-105.34%-408.51K

89.00%82.2K

-249.69%-60.2K

-323.58%-42.84K

-31.75%-96.07K

-911.13%-198.94K

Gain on sale of security

-247.37%-121.14K

27.61%-43.58K

725.73%268.08K

-346.89%-429.35K

-105.34%-408.51K

89.00%82.2K

-249.69%-60.2K

-323.58%-42.84K

-31.75%-96.07K

-911.13%-198.94K

Income before tax

4.73%-4.47M

-6.27%-8.14M

21.99%-3.99M

-26.81%-22.19M

-2.46%-4.71M

-3.13%-4.7M

-50.93%-7.66M

-56.55%-5.12M

-26.00%-17.5M

-42.38%-4.6M

Income tax

-48.76%10.99K

-95.45%1.21K

18.81%19.87K

-14.74%79.28K

-81.43%14.5K

430.04%21.46K

190.72%26.59K

897.50%16.73K

2,219.76%92.98K

1,047.42%78.11K

Net income

4.93%-4.49M

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

Net income continuous Operations

4.93%-4.49M

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

Minority interest income

Net income attributable to the parent company

4.93%-4.49M

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

4.93%-4.49M

-5.92%-8.14M

21.86%-4.01M

-26.59%-22.27M

-1.06%-4.72M

-3.51%-4.72M

-51.18%-7.69M

-56.98%-5.14M

-26.64%-17.59M

-45.17%-4.67M

Basic earnings per share

54.05%-0.17

32.26%-0.42

48.84%-0.22

-15.54%-1.71

25.64%-0.29

2.63%-0.37

-44.19%-0.62

-53.57%-0.43

-8.03%-1.48

-50.00%-0.39

Diluted earnings per share

54.05%-0.17

32.26%-0.42

48.84%-0.22

-15.54%-1.71

25.64%-0.29

2.63%-0.37

-44.19%-0.62

-53.57%-0.43

-8.03%-1.48

-50.00%-0.39

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	-60.62%55.18K	0	0	0	22.61%55.18K	-15.08%140.11K	0
Operating revenue	--0	--0	--0	-58.40%55.18K	--0	--0	--0	47.00%55.18K	-0.96%132.64K	--0
Cost of revenue
Gross profit
Operating expense	-8.72%4.46M	5.84%8.18M	-17.17%4.38M	24.51%22.31M	-3.38%4.41M	2.82%4.89M	46.66%7.73M	58.54%5.28M	28.06%17.92M	40.26%4.56M
Selling and administrative expenses	-27.02%1.84M	0.05%3.75M	-24.98%1.87M	13.08%10.79M	-11.11%2.03M	-9.64%2.52M	39.19%3.74M	40.33%2.49M	39.74%9.54M	28.54%2.29M
-General and administrative expense	-27.02%1.84M	0.05%3.75M	-24.98%1.87M	13.08%10.79M	-11.11%2.03M	-9.64%2.52M	39.19%3.74M	40.33%2.49M	39.74%9.54M	28.54%2.29M
Research and development costs	10.74%2.62M	11.28%4.44M	-10.19%2.51M	37.52%11.52M	4.40%2.37M	20.50%2.37M	54.44%3.99M	79.33%2.79M	16.93%8.38M	54.42%2.27M
Operating profit	8.72%-4.46M	-5.84%-8.18M	16.29%-4.38M	-25.18%-22.25M	3.38%-4.41M	-2.82%-4.89M	-49.35%-7.73M	-59.03%-5.23M	-28.58%-17.78M	-42.15%-4.56M
Net non-operating interest income expense	-0.56%105.41K	-34.94%84.53K	-24.16%115.3K	31.67%494.23K	-35.11%106.27K	-30.87%106K	116.91%129.93K	9,308.66%152.04K	2,904.06%375.36K	61,239.70%163.78K
Non-operating interest income	----	----	----	31.67%494.23K	----	----	----	----	--375.36K	----
Total other finance cost	0.56%-105.41K	34.94%-84.53K	24.16%-115.3K	----	----	30.87%-106K	---129.93K	-9,308.66%-152.04K	----	----
Other net income (expense)	-247.37%-121.14K	27.61%-43.58K	725.73%268.08K	-346.89%-429.35K	-105.34%-408.51K	89.00%82.2K	-249.69%-60.2K	-323.58%-42.84K	-31.75%-96.07K	-911.13%-198.94K
Gain on sale of security	-247.37%-121.14K	27.61%-43.58K	725.73%268.08K	-346.89%-429.35K	-105.34%-408.51K	89.00%82.2K	-249.69%-60.2K	-323.58%-42.84K	-31.75%-96.07K	-911.13%-198.94K
Income before tax	4.73%-4.47M	-6.27%-8.14M	21.99%-3.99M	-26.81%-22.19M	-2.46%-4.71M	-3.13%-4.7M	-50.93%-7.66M	-56.55%-5.12M	-26.00%-17.5M	-42.38%-4.6M
Income tax	-48.76%10.99K	-95.45%1.21K	18.81%19.87K	-14.74%79.28K	-81.43%14.5K	430.04%21.46K	190.72%26.59K	897.50%16.73K	2,219.76%92.98K	1,047.42%78.11K
Net income	4.93%-4.49M	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M
Net income continuous Operations	4.93%-4.49M	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M
Minority interest income
Net income attributable to the parent company	4.93%-4.49M	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	4.93%-4.49M	-5.92%-8.14M	21.86%-4.01M	-26.59%-22.27M	-1.06%-4.72M	-3.51%-4.72M	-51.18%-7.69M	-56.98%-5.14M	-26.64%-17.59M	-45.17%-4.67M
Basic earnings per share	54.05%-0.17	32.26%-0.42	48.84%-0.22	-15.54%-1.71	25.64%-0.29	2.63%-0.37	-44.19%-0.62	-53.57%-0.43	-8.03%-1.48	-50.00%-0.39
Diluted earnings per share	54.05%-0.17	32.26%-0.42	48.84%-0.22	-15.54%-1.71	25.64%-0.29	2.63%-0.37	-44.19%-0.62	-53.57%-0.43	-8.03%-1.48	-50.00%-0.39
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data